{"filings":[{"id":99342,"accession_number":"0001437749-26-015749","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q1 revenue $47.4M, GAAP EPS -$0.03; backlog record $115.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $47.4M, down 6.5% YoY; Battery & Energy sales -4.7%, Communications Systems -25.7%.","GAAP net loss ($0.5M) or ($0.03) per share vs $1.9M/$0.11 prior year; adjusted EBITDA $3.2M vs $5.4M.","Gross margin 21.3% (down from 25.1%); operating loss ($0.2M) including $1.7M one-time costs from power outage, inventory integration, and weather.","Backlog record $115.1M, highest ever, up from $110.2M at Q4 2025 and $95.0M at Q1 2025.","Management focusing on improving manufacturing efficiencies and driving orders to restore profitability and generate cash flow."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":47445000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115278,"accession_number":"0001437749-26-007567","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q4 revenue $48.5M, but operating loss of $10.6M on $12.2M impairment; GAAP EPS ($0.45)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $48.5M (+10.6% YoY); operating loss ($10.6M) vs profit $1.5M last year, driven by $12.2M intangible asset impairment.","GAAP EPS ($0.45) includes ($0.57) impairment charge; adjusted EBITDA $5.7M (11.7% sales) vs $3.9M.","Battery & Energy sales $45.9M (+15.1% YoY); Communications Systems $2.6M (-35.2%).","Backlog $110.2M (+22% from Q3); management expects improved 2026 results.","Rebranding consolidates sub-brands under Ultralife; expects $1.4M tax credit under 45X."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131691,"accession_number":"0001437749-25-035515","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q3 sales up 21.5% to $43.4M; GAAP loss per share of $0.07 on Calgary closure charge","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $43.4M (+21.5% YoY, including Electrochem); organic growth 2.5%. Backlog $90.1M vs $84.5M at Q2 2025.","GAAP EPS ($0.07) vs $0.02; operating loss $1.0M includes $1.1M non-recurring costs (Calgary facility closure).","Gross margin 22.2% down from 24.3% on raw material quality issues; adjusted EBITDA $2.0M vs $1.9M.","Battery & Energy Products sales +22.8% (ex-Electrochem +1.9%); government/defense sales +19.0%.","Calgary closure charge $0.5M; expected annual savings ~$0.8M after completion in Q1 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":142678000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148260,"accession_number":"0001437749-25-027836","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Ultralife replaces auditor Freed Maxick with Withum Smith+Brown effective immediately","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Auditor change due to acquisition of certain assets of Freed Maxick by Withum Smith+Brown.","Prior auditor's reports for FY2023 and FY2024 had no adverse opinions or qualifications.","FY2024 internal control opinion did note a material weakness in internal control over financial reporting.","No disagreements or reportable events with Freed Maxick during the relevant periods.","Audit committee engaged Withum as the new independent auditor for FY2025 effective August 22, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148259,"accession_number":"0001437749-25-025482","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q2 revenue up 13% to $48.6M on Electrochem; margin down, GAAP EPS $0.05 vs $0.18","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $48.6M (+13% YoY); organic Battery & Energy flat, Communications Systems down 57.2% to $2.7M.","Gross margin fell to 23.9% from 26.9% due to product mix, tariffs, and lower factory throughput.","Operating income $2.3M vs $3.9M; GAAP EPS $0.05 vs $0.18; adjusted EPS $0.07 vs $0.22.","Backlog with high-confidence orders $89M vs $95M at Q1 2025; debt prepaid $2.7M.","CEO expects improved results in H2 2025 on rebound in Communications and new product orders."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":99307000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148258,"accession_number":"0001437749-25-022930","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ultralife stockholders elect directors and ratify auditor at 2025 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Met quorum with 14,196,720 shares (85.35%) out of 16,632,965 outstanding.","Elected directors: Michael Manna, Janie Goddard, Thomas Saeli, Robert Shaw II, Bradford Whitmore; all received overwhelming 'for' votes.","Ratified Freed Maxick P.C. as independent auditor for 2025: 14,042,572 for, 61,028 against, 21,888 abstain.","No shareholder proposals or contested matters were presented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167030,"accession_number":"0001437749-25-015629","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q1 revenue $50.7M (+21% YoY); GAAP EPS $0.11 vs $0.18","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $50.7M, up 21% YoY; Battery & Energy Products +32.4% to $46.3M (incl. Electrochem, organic +10.6%).","GAAP EPS $0.11 vs $0.18 YoY; adjusted EPS $0.13 vs $0.21; operating income $3.4M vs $4.1M.","Gross margin 25.1% (vs 27.4% YoY) on product mix; Communications Systems sales fell 36.2% to $4.4M.","Backlog $95.0M vs $102.2M at Q4 2024; company cites strong replenishment and tariff mitigation plan."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":50746000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167029,"accession_number":"0001437749-25-010359","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-04-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q4 GAAP EPS $0.01 vs $0.17 YoY; sales $43.9M; backlog $102.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $43.9M, down from $44.5M YoY; Battery & Energy +11.7%, Communications -55.1%.","GAAP EPS $0.01 ($0.2M net income) vs $0.17 ($2.9M) in Q4 2023; adjusted EPS also $0.01.","Operating income $1.5M including $1.1M one-time acquisition costs; adjusted EBITDA $3.9M.","Full-year sales $164.5M (+3.7%); GAAP EPS $0.38 vs $0.44; adjusted EBITDA $16.5M.","Backlog and high-confidence orders $102.2M at year-end 2024 vs $78.0M at Q3 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":50746000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184408,"accession_number":"0001437749-25-001267","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K/A","filed_at":"2025-01-16T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Ultralife files amended 8-K with audited financials for Electrochem acquisition","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Ultralife Corporation (ULBI) filed an 8-K/A on Jan 16, 2025, amending its Nov 6, 2024 report.","The amendment adds audited financial statements of Electrochem Solutions as of Dec 31, 2023.","Pro forma unaudited combined financial information for Sep 30, 2024 and Dec 31, 2023 is included.","Electrochem was acquired from Integer Holdings Corp. (ITGR) on Oct 31, 2024.","Philip A. Fain signed the filing; exhibits include audited statements by Freed Maxick P.C."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201009,"accession_number":"0001437749-24-034046","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q3 EPS $0.02 vs $0.08; revenue $35.7M (-9.6%); backlog $78M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS $0.02, down from $0.08; net income $0.3M vs $1.3M Q3 2023.","Revenue $35.7M, down 9.6% YoY; Battery & Energy +1.9%, Communications Systems -58.2%.","Backlog $78.0M; debt reduced 33.4% to $8.0M from $12.1M at Q2 end.","Acquisition of Electrochem Solutions completed Oct 31; related costs $0.3M in Q3."],"consensus_eps_estimate":null,"consensus_eps_actual":0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":120604000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201008,"accession_number":"0001437749-24-033673","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["1.01","2.01","2.03","7.01","9.01"],"status":"ready","headline":"Ultralife completes $50M acquisition of Electrochem Solutions; secures $55M term loan","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired all shares of Electrochem from Integer Holdings (NYSE: ITGR) for $50M cash on Oct 31, 2024.","Electrochem designs primary lithium metal and ultracapacitor cells; trailing 12-month revenue of $34M.","Funded via new $55M senior secured term loan from KeyBank, M&T, and Community Bank, maturing Oct 31, 2029.","CEO Mike Manna expects cross-selling opportunities, scale efficiencies, and expanded market reach.","Financial statements and pro forma financial information to be filed within 71 days of this report."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201007,"accession_number":"0001437749-24-030645","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-10-03T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Ultralife acquires Electrochem Solutions for $50M; expects EPS accretive in 2025","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $50M cash; transaction expected to close by end of October 2024.","Electrochem had trailing 12-month revenue of $34M as of June 30, 2024.","Deal expected accretive on EPS basis for 2025; financed via amended credit facilities.","Khristine Carroll to join as SVP-GM of Electrochem upon closing.","Acquisition targets gross margin expansion through vertical integration and synergies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217014,"accession_number":"0001437749-24-023415","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-07-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q2 sales $43.0M (+0.7%); Battery segment record; debt cut 52% to $12.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $43.0M vs $42.7M; Battery & Energy Products segment record $36.7M, up 8.3% YoY.","Gross margin improved 210 bps to 26.9%; Battery gross margin up 480 bps to 27.1%.","GAAP EPS $0.18 vs $0.21 (last year included $0.07 ERC); Adjusted EPS $0.22.","Backlog $93.0M; reduced debt by $13.2M (52.2%) to $12.1M.","Received $0.2M preliminary insurance payment for 2023 cyberattack."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":84910000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217013,"accession_number":"0001437749-24-022896","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ultralife shareholders approve 2024 LTIP, reject majority-vote proposal at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All five directors elected with broker non-votes of ~2.5M shares each.","Ratification of Freed Maxick CPAs as auditor for 2024: 13.5M for, 98k against.","Approval of 2024 Long-Term Incentive Plan: 9.1M for, 1.9M against, 2.5M broker non-votes.","Shareholder proposal for majority vote to elect directors failed: 3.3M for, 7.6M against.","Quorum of 13.6M shares (81.68% of outstanding) present."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236775,"accession_number":"0001437749-24-013119","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q1 sales up 31.4% to $41.9M; GAAP EPS $0.18 vs -$0.02 YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $41.9M (+31.4% YoY); government/defense sales +83.4%, medical battery sales +54.7%.","GAAP EPS $0.18 vs net loss $0.02; adjusted EPS $0.21. Operating income $4.1M vs breakeven.","Gross margin 27.4% vs 23.3% YoY; Battery & Energy margin 25.7% vs 22.9%.","Backlog $97.4M; adjusted EBITDA $5.2M (12.5% of sales) vs $1.2M (3.6%).","CEO cites gross margin initiatives and core product demand; expects profitable growth and cash flow."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":41927000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254383,"accession_number":"0001437749-24-004266","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-02-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q4 revenue $44.5M (+23.4% YoY); adjusted EPS $0.18 vs -$0.03","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 sales $44.5M, up 23.4% YoY; full-year sales $158.6M, up 20.3%.","Q4 operating income $3.6M vs $0.2M; full-year $9.5M vs $0.1M.","Q4 adjusted EPS $0.18 vs loss of $0.03; full-year adjusted EPS $0.52 vs loss of $0.07.","Medical battery sales highest quarter ever; Battery & Energy gross margin expanded 360 bps to 25.2%.","Backlog $103.5M at year-end; management plans to pay down acquisition debt."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":158644000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}